Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;33(9):1359-1361.
doi: 10.1038/s41433-019-0434-y. Epub 2019 Apr 9.

Biotherapeutics and immunogenicity: ophthalmic perspective

Ashish Sharma  1 , Nilesh Kumar  2 , Baruch D Kuppermann  3 , Francesco Bandello  4 , Anat Loewenstein  5
Affiliations

Biotherapeutics and immunogenicity: ophthalmic perspective

Ashish Sharma et al. Eye (Lond). 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Yorston D. Anti-VEGF drugs in the prevention of blindness. Community Eye Health. 2014;27:44–6. - PMC - PubMed
    1. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209–13. doi: 10.1016/j.ajo.2011.10.016. - DOI - PubMed
    1. Bressler NM, Doan QV, Varma R, Lee PP, Suñer IJ, Dolan C, et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol [Internet]. 2011;129. http://archopht.jamanetwork.com/article.aspx?10.1001/archophthalmol.2011.140. Accessed 26 Feb 2019. - PubMed
    1. Kiss S, Dugel PU, Khanani AM, Broder MS, Chang E, Sun GH, et al. Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis. Clin Ophthalmol. 2018;12:1625–35. doi: 10.2147/OPTH.S169143. - DOI - PMC - PubMed
    1. Souied EH, Dugel PU, Ferreira A, Hashmonay R, Lu J, Kelly SP. Severe ocular inflammation following ranibizumab or aflibercept injections for age-related macular degeneration: a retrospective claims database analysis. Ophthalmic Epidemiol. 2016;23:71–9. doi: 10.3109/09286586.2015.1090004. - DOI - PMC - PubMed

Substances